Conference Coverage

Fluarix Quadrivalent effective in very young, simplifies flu shots for all ages


 

FROM AN ACIP MEETING


“These study results support universal vaccination of all individuals from 6 months of age [with Fluarix] to prevent influenza.” Dr. Friedland concluded.

For live updates and information concerning influenza, visit the CDC website.

ilacy@frontlinemedcom.com

SOURCE: D-QIV-004.

Pages

Recommended Reading

Novel herpes zoster vaccine is more cost effective than old vaccine
MDedge Infectious Disease
DMARDs may hamper pneumococcal vaccine response in systemic sclerosis patients
MDedge Infectious Disease
Birth cohort affected 2015-2016 flu vaccine effectiveness
MDedge Infectious Disease
Adacel Tdap effective throughout third trimester vaccination window
MDedge Infectious Disease
Hospitals filling as flu season worsens
MDedge Infectious Disease
Children with sickle cell anemia fall short on antibiotic adherence
MDedge Infectious Disease
This is what a flu pandemic looks like
MDedge Infectious Disease
MMWR: Current flu vaccine does not protect elderly
MDedge Infectious Disease
Inflammatory markers predict vaccine response in HCV, HIV
MDedge Infectious Disease
ACIP unanimously recommends HEPLISAV-B
MDedge Infectious Disease